227 related articles for article (PubMed ID: 11882328)
1. Endothelial markers and adhesion molecules in acute ischemic stroke--sequential change and differences in stroke subtype.
Kozuka K; Kohriyama T; Nomura E; Ikeda J; Kajikawa H; Nakamura S
Atherosclerosis; 2002 Mar; 161(1):161-8. PubMed ID: 11882328
[TBL] [Abstract][Full Text] [Related]
2. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.
Cherian P; Hankey GJ; Eikelboom JW; Thom J; Baker RI; McQuillan A; Staton J; Yi Q
Stroke; 2003 Sep; 34(9):2132-7. PubMed ID: 12907813
[TBL] [Abstract][Full Text] [Related]
3. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis.
Zhang Q; Zeng C; Fu Y; Cheng Z; Zhang J; Liu Z
Nephrology (Carlton); 2012 May; 17(4):338-45. PubMed ID: 22295953
[TBL] [Abstract][Full Text] [Related]
5. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers.
Seljeflot I; Arnesen H; Brude IR; Nenseter MS; Drevon CA; Hjermann I
Eur J Clin Invest; 1998 Aug; 28(8):629-35. PubMed ID: 9767357
[TBL] [Abstract][Full Text] [Related]
6. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
7. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
8. Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease.
Lavallée PC; Labreuche J; Faille D; Huisse MG; Nicaise-Roland P; Dehoux M; Gongora-Rivera F; Jaramillo A; Brenner D; Deplanque D; Klein IF; Touboul PJ; Vicaut E; Ajzenberg N;
Cerebrovasc Dis; 2013; 36(2):131-8. PubMed ID: 24029712
[TBL] [Abstract][Full Text] [Related]
9. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis.
Frijns CJ; Kappelle LJ; van Gijn J; Nieuwenhuis HK; Sixma JJ; Fijnheer R
Stroke; 1997 Nov; 28(11):2214-8. PubMed ID: 9368567
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
[TBL] [Abstract][Full Text] [Related]
12. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
[TBL] [Abstract][Full Text] [Related]
13. sP- and sE-selectin in stroke patients with metabolic disorders.
Pawelczyk M; Glabiński A; Kaczorowska B; Baj Z
Neurol Neurochir Pol; 2018; 52(5):599-605. PubMed ID: 30190210
[TBL] [Abstract][Full Text] [Related]
14. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Blann AD; Lip GY
Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
[TBL] [Abstract][Full Text] [Related]
15. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Lip GY; Lydakis C; Nuttall SL; Landray MJ; Watson RD; Blann AD
J Intern Med; 2000 Oct; 248(4):316-8. PubMed ID: 11086642
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease.
Tsakiris DA; Tschöpl M; Jäger K; Haefeli WE; Wolf F; Marbet GA
Atherosclerosis; 1999 Jan; 142(1):193-200. PubMed ID: 9920521
[TBL] [Abstract][Full Text] [Related]
18. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.
Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ
J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416
[TBL] [Abstract][Full Text] [Related]
19. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
Circulation; 2002 Oct; 106(15):1962-7. PubMed ID: 12370220
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
